D

Dongkook Pharmaceutical Co Ltd
KOSDAQ:086450

Watchlist Manager
Dongkook Pharmaceutical Co Ltd
KOSDAQ:086450
Watchlist
Price: 16 710 KRW 2.26% Market Closed
Market Cap: 734.6B KRW
Have any thoughts about
Dongkook Pharmaceutical Co Ltd?
Write Note

Dongkook Pharmaceutical Co Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Dongkook Pharmaceutical Co Ltd
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
D
Dongkook Pharmaceutical Co Ltd
KOSDAQ:086450
Operating Income
â‚©83.2B
CAGR 3-Years
7%
CAGR 5-Years
7%
CAGR 10-Years
12%
Yuhan Corp
KRX:000100
Operating Income
â‚©72.6B
CAGR 3-Years
-5%
CAGR 5-Years
44%
CAGR 10-Years
0%
SK Biopharmaceuticals Co Ltd
KRX:326030
Operating Income
-â‚©37.5B
CAGR 3-Years
46%
CAGR 5-Years
23%
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Operating Income
â‚©255.8B
CAGR 3-Years
27%
CAGR 5-Years
23%
CAGR 10-Years
19%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Operating Income
â‚©4.2B
CAGR 3-Years
N/A
CAGR 5-Years
-28%
CAGR 10-Years
-14%
C
Celltrion Pharm Inc
KOSDAQ:068760
Operating Income
â‚©29.3B
CAGR 3-Years
-15%
CAGR 5-Years
24%
CAGR 10-Years
15%
No Stocks Found

Dongkook Pharmaceutical Co Ltd
Glance View

Market Cap
734.7B KRW
Industry
Pharmaceuticals

DongKook Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceuticals. The company is headquartered in Seoul, Seoul. The company went IPO on 2007-05-29. The firm develops and provides remedies for oral troubles, skin troubles and gynecology diseases, contrast mediums, anesthetics, anticancer medicines and circulatory system agents. The company also provides other pharmaceuticals, such as remedies for arthritis and pancreatitis, antiphlogistic, anodynes, antibiotics and vitamins, as well as raw materials for pharmaceuticals. In addition, it is engaged in the rental business. The firm distributes its products within domestic market and to overseas markets, such as Japan, Germany, India, Brazil and Mexico, among others.

Intrinsic Value
19 388.02 KRW
Undervaluation 14%
Intrinsic Value
Price
D

See Also

What is Dongkook Pharmaceutical Co Ltd's Operating Income?
Operating Income
83.2B KRW

Based on the financial report for Sep 30, 2024, Dongkook Pharmaceutical Co Ltd's Operating Income amounts to 83.2B KRW.

What is Dongkook Pharmaceutical Co Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
12%

Over the last year, the Operating Income growth was 30%. The average annual Operating Income growth rates for Dongkook Pharmaceutical Co Ltd have been 7% over the past three years , 7% over the past five years , and 12% over the past ten years .

Back to Top